Global Recombinant Human Endostatin Sales Market Report Forecast 2017-2021

May 2017 | 105 pages | ID: G5F4B9E2BC2EN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:

Pfizer
Biocon
Mabtech
Novartis
Fujifilm Kyowa Kirin Biologics
Enzon Pharmaceuticals
Genexine
Hetero Drugs
Onyx Pharmaceuticals

Product Segment Analysis:

• Type 1
• Type 2
• Type 3

Application Segment Analysis:

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 RECOMBINANT HUMAN ENDOSTATIN MARKET OVERVIEW

1.1 Product Overview and Scope of Recombinant Human Endostatin
1.2 Classification of Recombinant Human Endostatin
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Recombinant Human Endostatin
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Recombinant Human Endostatin Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Recombinant Human Endostatin (2012-2021)
  1.5.1 Global Recombinant Human Endostatin Sales and Growth Rate (2012-2021)
  1.5.2 Global Recombinant Human Endostatin Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON RECOMBINANT HUMAN ENDOSTATIN INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 RECOMBINANT HUMAN ENDOSTATIN MANUFACTURING COST ANALYSIS

3.1 Recombinant Human Endostatin Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Recombinant Human Endostatin

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Recombinant Human Endostatin Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL RECOMBINANT HUMAN ENDOSTATIN COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Recombinant Human Endostatin Market Competition by Manufacturers
  5.1.1 Global Recombinant Human Endostatin Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Recombinant Human Endostatin Revenue and Share by Manufacturers (2012-2017)
5.2 Global Recombinant Human Endostatin (Volume and Value) by Type
  5.5.1 Global Recombinant Human Endostatin Sales and Market Share by Type (2012-2017)
  5.5.2 Global Recombinant Human Endostatin Revenue and Market Share by Type (2012-2017)
5.3 Global Recombinant Human Endostatin (Volume and Value) by Regions
  5.3.1 Global Recombinant Human Endostatin Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Recombinant Human Endostatin Revenue and Market Share by Regions (2012-2017)
5.4 Global Recombinant Human Endostatin (Volume) by Application

6 UNITED STATES RECOMBINANT HUMAN ENDOSTATIN (VOLUME, VALUE AND SALES PRICE)

6.1 United States Recombinant Human Endostatin Sales and Value (2012-2017)
  6.1.1 United States Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
  6.1.2 United States Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
  6.1.3 United States Recombinant Human Endostatin Sales Price Trend (2012-2017)
6.2 United States Recombinant Human Endostatin Sales and Market Share by Manufacturers
6.3 United States Recombinant Human Endostatin Sales and Market Share by Type
6.4 United States Recombinant Human Endostatin Sales and Market Share by Application

7 CHINA RECOMBINANT HUMAN ENDOSTATIN (VOLUME, VALUE AND SALES PRICE)

7.1 China Recombinant Human Endostatin Sales and Value (2012-2017)
  7.1.1 China Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
  7.1.2 China Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
  7.1.3 China Recombinant Human Endostatin Sales Price Trend (2012-2017)
7.2 China Recombinant Human Endostatin Sales and Market Share by Manufacturers
7.3 China Recombinant Human Endostatin Sales and Market Share by Type
7.4 China Recombinant Human Endostatin Sales and Market Share by Application

8 EUROPE RECOMBINANT HUMAN ENDOSTATIN (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Recombinant Human Endostatin Sales and Value (2012-2017)
  8.1.1 Europe Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
  8.1.2 Europe Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Recombinant Human Endostatin Sales Price Trend (2012-2017)
8.2 Europe Recombinant Human Endostatin Sales and Market Share by Manufacturers
8.3 Europe Recombinant Human Endostatin Sales and Market Share by Type
8.4 Europe Recombinant Human Endostatin Sales and Market Share by Application

9 JAPAN RECOMBINANT HUMAN ENDOSTATIN (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Recombinant Human Endostatin Sales and Value (2012-2017)
  9.1.1 Japan Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
  9.1.2 Japan Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Recombinant Human Endostatin Sales Price Trend (2012-2017)
9.2 Japan Recombinant Human Endostatin Sales and Market Share by Manufacturers
9.3 Japan Recombinant Human Endostatin Sales and Market Share by Type
9.4 Japan Recombinant Human Endostatin Sales and Market Share by Application

10 GLOBAL RECOMBINANT HUMAN ENDOSTATIN MANUFACTURERS ANALYSIS

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Biocon
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Mabtech
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Novartis
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Fujifilm Kyowa Kirin Biologics
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Enzon Pharmaceuticals
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Genexine
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Hetero Drugs
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Onyx Pharmaceuticals
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL RECOMBINANT HUMAN ENDOSTATIN MARKET FORECAST (2017-2021)

13.1 Global Recombinant Human Endostatin Sales, Revenue Forecast (2017-2021)
13.2 Global Recombinant Human Endostatin Sales Forecast by Regions (2017-2021)
13.3 Global Recombinant Human Endostatin Sales Forecast by Type (2017-2021)
13.4 Global Recombinant Human Endostatin Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

FIGURE PICTURE OF RECOMBINANT HUMAN ENDOSTATIN

Table Classification of Recombinant Human Endostatin
Figure Global Sales Market Share of Recombinant Human Endostatin by Type in 2015
Table Applications of Recombinant Human Endostatin
Figure Global Sales Market Share of Recombinant Human Endostatin by Application in 2015
Figure United States Recombinant Human Endostatin Revenue and Growth Rate (2012-2021)
Figure China Recombinant Human Endostatin Revenue and Growth Rate (2012-2021)
Figure Europe Recombinant Human Endostatin Revenue and Growth Rate (2012-2021)
Figure Japan Recombinant Human Endostatin Revenue and Growth Rate (2012-2021)
Figure Global Recombinant Human Endostatin Sales and Growth Rate (2012-2021)
Figure Global Recombinant Human Endostatin Revenue and Growth Rate (2012-2021)
Table Global Recombinant Human Endostatin Sales of Key Manufacturers (2012-2017)
Table Global Recombinant Human Endostatin Sales Share by Manufacturers (2012-2017)
Figure 2015 Recombinant Human Endostatin Sales Share by Manufacturers
Figure 2016 Recombinant Human Endostatin Sales Share by Manufacturers
Table Global Recombinant Human Endostatin Revenue by Manufacturers (2012-2017)
Table Global Recombinant Human Endostatin Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Recombinant Human Endostatin Revenue Share by Manufacturers
Table 2016 Global Recombinant Human Endostatin Revenue Share by Manufacturers
Table Global Recombinant Human Endostatin Sales and Market Share by Type (2012-2017)
Table Global Recombinant Human Endostatin Sales Share by Type (2012-2017)
Figure Sales Market Share of Recombinant Human Endostatin by Type (2012-2017)
Figure Global Recombinant Human Endostatin Sales Growth Rate by Type (2012-2017)
Table Global Recombinant Human Endostatin Revenue and Market Share by Type (2012-2017)
Table Global Recombinant Human Endostatin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Human Endostatin by Type (2012-2017)
Figure Global Recombinant Human Endostatin Revenue Growth Rate by Type (2012-2017)
Table Global Recombinant Human Endostatin Sales and Market Share by Regions (2012-2017)
Table Global Recombinant Human Endostatin Sales Share by Regions (2012-2017)
Figure Sales Market Share of Recombinant Human Endostatin by Regions (2012-2017)
Figure Global Recombinant Human Endostatin Sales Growth Rate by Regions (2012-2017)
Table Global Recombinant Human Endostatin Revenue and Market Share by Regions (2012-2017)
Table Global Recombinant Human Endostatin Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Recombinant Human Endostatin by Regions (2012-2017)
Figure Global Recombinant Human Endostatin Revenue Growth Rate by Regions (2012-2017)
Table Global Recombinant Human Endostatin Sales and Market Share by Application (2012-2017)
Table Global Recombinant Human Endostatin Sales Share by Application (2012-2017)
Figure Sales Market Share of Recombinant Human Endostatin by Application (2012-2017)
Figure Global Recombinant Human Endostatin Sales Growth Rate by Application (2012-2017)
Figure United States Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
Figure United States Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
Figure United States Recombinant Human Endostatin Sales Price Trend (2012-2017)
Table United States Recombinant Human Endostatin Sales by Manufacturers (2012-2017)
Table United States Recombinant Human Endostatin Market Share by Manufacturers (2012-2017)
Table United States Recombinant Human Endostatin Sales by Type (2012-2017)
Table United States Recombinant Human Endostatin Market Share by Type (2012-2017)
Table United States Recombinant Human Endostatin Sales by Application (2012-2017)
Table United States Recombinant Human Endostatin Market Share by Application (2012-2017)
Figure China Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
Figure China Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
Figure China Recombinant Human Endostatin Sales Price Trend (2012-2017)
Table China Recombinant Human Endostatin Sales by Manufacturers (2012-2017)
Table China Recombinant Human Endostatin Market Share by Manufacturers (2012-2017)
Table China Recombinant Human Endostatin Sales by Type (2012-2017)
Table China Recombinant Human Endostatin Market Share by Type (2012-2017)
Table China Recombinant Human Endostatin Sales by Application (2012-2017)
Table China Recombinant Human Endostatin Market Share by Application (2012-2017)
Figure Europe Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
Figure Europe Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
Figure Europe Recombinant Human Endostatin Sales Price Trend (2012-2017)
Table Europe Recombinant Human Endostatin Sales by Manufacturers (2012-2017)
Table Europe Recombinant Human Endostatin Market Share by Manufacturers (2012-2017)
Table Europe Recombinant Human Endostatin Sales by Type (2012-2017)
Table Europe Recombinant Human Endostatin Market Share by Type (2012-2017)
Table Europe Recombinant Human Endostatin Sales by Application (2012-2017)
Table Europe Recombinant Human Endostatin Market Share by Application (2012-2017)
Figure Japan Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
Figure Japan Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
Figure Japan Recombinant Human Endostatin Sales Price Trend (2012-2017)
Table Japan Recombinant Human Endostatin Sales by Manufacturers (2012-2017)
Table Japan Recombinant Human Endostatin Market Share by Manufacturers (2012-2017)
Table Japan Recombinant Human Endostatin Sales by Type (2012-2017)
Table Japan Recombinant Human Endostatin Market Share by Type (2012-2017)
Table Japan Recombinant Human Endostatin Sales by Application (2012-2017)
Table Japan Recombinant Human Endostatin Market Share by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Recombinant Human Endostatin Global Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biocon Recombinant Human Endostatin Global Market Share (2012-2017)
Table Mabtech Basic Information List
Table Mabtech Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Mabtech Recombinant Human Endostatin Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Recombinant Human Endostatin Global Market Share (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Global Market Share (2012-2017)
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Enzon Pharmaceuticals Recombinant Human Endostatin Global Market Share (2012-2017)
Table Genexine Basic Information List
Table Genexine Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genexine Recombinant Human Endostatin Global Market Share (2012-2017)
Table Hetero Drugs Basic Information List
Table Hetero Drugs Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hetero Drugs Recombinant Human Endostatin Global Market Share (2012-2017)
Table Onyx Pharmaceuticals Basic Information List
Table Onyx Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Onyx Pharmaceuticals Recombinant Human Endostatin Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Human Endostatin
Figure Manufacturing Process Analysis of Recombinant Human Endostatin
Figure Recombinant Human Endostatin Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015
Table Major Buyers of Recombinant Human Endostatin
Table Distributors/Traders List
Figure Global Recombinant Human Endostatin Sales and Growth Rate Forecast (2017-2021)
Figure Global Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2021)
Table Global Recombinant Human Endostatin Sales Forecast by Regions (2017-2021)
Table Global Recombinant Human Endostatin Sales Forecast by Type (2017-2021)
Table Global Recombinant Human Endostatin Sales Forecast by Application (2017-2021)